Literature DB >> 35535105

Comparison of Anthropometry, Bioelectrical Impedance, and Dual-energy X-ray Absorptiometry for Body Composition in Cirrhosis.

Indu Grover1, Namrata Singh1, Deepak Gunjan1, Ravindra M Pandey2, Hem Chandra Sati2, Anoop Saraya1.   

Abstract

Background & aims: This study was planned to evaluate triceps skinfold thickness (TSFT), mid-arm muscle circumference (MAMC) and bioelectrical impedance analysis (BIA) for assessing body composition using dual-energy X-ray absorptiometry (DEXA) (reference) and to predict fat mass (FM) and fat-free mass (FFM) in patients with cirrhosis.
Methods: FM and FFM were assessed by using DEXA and BIA. Skin-fold calliper was used for measuring TSFT, and MAMC was calculated. Bland-Altman plot was used to determine agreement and linear regression analysis for obtaining equations to predict FM and FFM.
Results: Patients with cirrhosis (n = 302, 241 male, age 43.7 ± 12.0 years) were included. Bland-Altman plot showed very good agreement between BIA and DEXA for the estimation of FM and FFM. Majority of patients were within the limit of agreement: FM (98%) and FFM (96.4%). BIA shows a positive correlation with DEXA:FM (r = 0.73, P ≤ 0.001) and FFM (r = 0.86, P ≤ 0.001). DEXA (FM and FFM) shows a positive correlation with TSFT (r = 0.69, P ≤ 0.01) and MAMC (r = 0.61, P ≤ 0.01). The mean difference between the observed and predicted value of FM and FFM by BIA in the developmental set was 0.01 and 0.05, respectively; whereas in the validation set, it was -0.13 and 0.86, respectively. The mean difference between the observed and predicted value of TSFT and MAMC in the developmental set was 0.43 and 0.07; whereas, in the validation set, it was 0.16 and 0.48, respectively.
Conclusion: Anthropometry (TSFT and MAMC) and BIA are simple and easy to use and can be a substitute of DEXA for FM and FFM assessment in routine clinical settings in patients with cirrhosis.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALP, alkaline phosphatise; ALT, alanine aminotransferase; ANA, anti-nuclear antibody; ASMA, anti-smooth muscle antibody; AST, aspartate aminotransferase; BIA, bioelectrical impedance analysis; BMC, bone mineral content; BMI, body mass index; CTP, Child–Turcotte–Pugh score; DEXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; FM, fat mass; HBsAg, hepatitis B surface antigen; MAMC, mid-arm muscle circumference; TSFT, triceps skinfold thickness; anthropometric measurements; anti-HCV, anti-hepatitis C virus; anti-LKM1, anti-liver kidney microsomal antibody type 1; bioelectrical impedance analysis; cirrhosis; dual-energy X-ray absorptiometry; nutritional assessment

Year:  2021        PMID: 35535105      PMCID: PMC9077186          DOI: 10.1016/j.jceh.2021.05.012

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  27 in total

1.  A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients.

Authors:  P Fiore; M Merli; A Andreoli; A De Lorenzo; A Masini; L Ciuffa; V Valeriano; M T Balotta; O Riggio
Journal:  Clin Nutr       Date:  1999-12       Impact factor: 7.324

2.  Bioelectrical impedance analysis-part II: utilization in clinical practice.

Authors:  Ursula G Kyle; Ingvar Bosaeus; Antonio D De Lorenzo; Paul Deurenberg; Marinos Elia; José Manuel Gómez; Berit Lilienthal Heitmann; Luisa Kent-Smith; Jean-Claude Melchior; Matthias Pirlich; Hermann Scharfetter; Annemie M W J Schols; Claude Pichard
Journal:  Clin Nutr       Date:  2004-12       Impact factor: 7.324

Review 3.  Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation.

Authors:  Leigh C Ward
Journal:  Eur J Clin Nutr       Date:  2018-10-08       Impact factor: 4.016

4.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2018-04-10       Impact factor: 25.083

5.  Nutrition and survival in patients with liver cirrhosis.

Authors:  F Alberino; A Gatta; P Amodio; C Merkel; L Di Pascoli; G Boffo; L Caregaro
Journal:  Nutrition       Date:  2001-06       Impact factor: 4.008

Review 6.  Nutrition in chronic liver disease and liver transplantation.

Authors:  E Cabré; M A Gassull
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1998-09       Impact factor: 4.294

7.  Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis.

Authors:  Oliver Selberg; Daniela Selberg
Journal:  Eur J Appl Physiol       Date:  2002-01-31       Impact factor: 3.078

8.  Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study.

Authors:  Bernard Campillo; Jean-Philippe Richardet; Elizabeth Scherman; Phuong Nhi Bories
Journal:  Nutrition       Date:  2003-06       Impact factor: 4.008

9.  Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies.

Authors:  C Mendenhall; G A Roselle; P Gartside; T Moritz
Journal:  Alcohol Clin Exp Res       Date:  1995-06       Impact factor: 3.455

Review 10.  A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

View more
  1 in total

1.  Untangling the Web of Malnutrition, Sarcopenia, and Frailty in Chronic Liver Disease.

Authors:  Vivek A Saraswat; Karan Kumar
Journal:  J Clin Exp Hepatol       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.